Page last updated: 2024-10-30

mesalamine and Cholecystoduodenal Fistula

mesalamine has been researched along with Cholecystoduodenal Fistula in 10 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"Diarrhea is a common clinical feature of inflammatory bowel diseases and may be accompanied by abdominal pain, urgency, and fecal incontinence."2.48Diarrhea in chronic inflammatory bowel diseases. ( Wenzl, HH, 2012)
"The aetiology of Crohn's disease still remains obscure, therefore medical therapy is directed towards symptomatic relief in active disease and relapse prevention in the long-term setting."2.42Review article: medical treatment of mild to moderately active Crohn's disease. ( Löfberg, R, 2003)
"Separate risk prediction models for Crohn's disease-related surgery and complications were developed using clinical trial data involving community gastroenterology practices."1.48Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease. ( Dulai, PS; Feagan, BG; Guizzetti, L; Jairath, V; Khanna, R; Sandborn, WJ; Zou, G, 2018)
"The incidence of Crohn's disease has steadily increased over the past several decades."1.48ACG Clinical Guideline: Management of Crohn's Disease in Adults. ( Gerson, LB; Isaacs, KL; Lichtenstein, GR; Loftus, EV; Regueiro, MD; Sands, BE, 2018)
"Prednisone dosage was reduced from a mean of 19."1.32Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions. ( France, R; Kinney, T; Kozarek, R; Patterson, D; Rawlins, M, 2003)
"Gastroduodenal Crohn disease is a complex and difficult problem that is associated with serious complications and need for reoperation."1.30An audit of gastroduodenal Crohn disease: clinicopathologic features and management. ( Allan, RN; Keighley, MR; Yamamoto, T, 1999)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guizzetti, L1
Zou, G1
Khanna, R1
Dulai, PS1
Sandborn, WJ1
Jairath, V1
Feagan, BG1
Lichtenstein, GR1
Loftus, EV1
Isaacs, KL1
Regueiro, MD1
Gerson, LB1
Sands, BE1
Gargallo Puyuelo, CJ1
Sopeña, F1
Lanas Arbeloa, A1
Hall, J1
Hammerich, K1
Roberts, P1
Wenzl, HH1
Kinney, T1
Rawlins, M1
Kozarek, R1
France, R1
Patterson, D1
Löfberg, R1
Caprilli, R1
Gassull, MA1
Escher, JC1
Moser, G1
Munkholm, P1
Forbes, A1
Hommes, DW1
Lochs, H1
Angelucci, E1
Cocco, A1
Vucelic, B1
Hildebrand, H1
Kolacek, S1
Riis, L1
Lukas, M1
de Franchis, R1
Hamilton, M1
Jantschek, G1
Michetti, P1
O'Morain, C1
Anwar, MM1
Freitas, JL1
Mouzas, IA1
Baert, F1
Mitchell, R1
Hawkey, CJ1
Treepongkaruna, S1
Pienvichit, P1
Sornmayura, P1
Pornkul, R1
Wisedopas, N1
Phuapradit, P1
Yamamoto, T1
Allan, RN1
Keighley, MR1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multicentre Controlled, Randomized Clinical Trial to Compare the Efficacy and Safety of Ambulatory Treatment of Mild Acute Diverticulitis Without Antibiotics With the Standard Treatment With Antibiotics[NCT02785549]Phase 4480 participants (Actual)Interventional2016-11-30Completed
Synbiotic Treatment in Crohn's Disease Patients[NCT00305409]50 participants (Anticipated)Interventional2006-06-30Completed
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)[NCT04578392]181 participants (Anticipated)Interventional2020-07-28Recruiting
A Randomized, Controlled, Open-label Study to Assess the Efficacy of T2 Versus Azathioprine for the Maintenance of Clinical and Endoscopic Remission in Subjects With Crohn's Disease After Surgical Resection[NCT01015391]100 participants (Anticipated)Interventional2009-11-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for mesalamine and Cholecystoduodenal Fistula

ArticleYear
Colonic diverticular disease. Treatment and prevention.
    Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:10

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Contraind

2015
New paradigms in the management of diverticular disease.
    Current problems in surgery, 2010, Volume: 47, Issue:9

    Topics: Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Diagnosis, D

2010
Diarrhea in chronic inflammatory bowel diseases.
    Gastroenterology clinics of North America, 2012, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections

2012
Review article: medical treatment of mild to moderately active Crohn's disease.
    Alimentary pharmacology & therapeutics, 2003, Volume: 17 Suppl 2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Colonic Diseases; Crohn Diseas

2003

Other Studies

6 other studies available for mesalamine and Cholecystoduodenal Fistula

ArticleYear
Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.
    Journal of Crohn's & colitis, 2018, Jan-24, Volume: 12, Issue:2

    Topics: Abdominal Abscess; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroi

2018
ACG Clinical Guideline: Management of Crohn's Disease in Adults.
    The American journal of gastroenterology, 2018, Volume: 113, Issue:4

    Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Certolizumab Pegol; Crohn Disease; Dise

2018
Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy,

2003
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.
    Gut, 2006, Volume: 55 Suppl 1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone Diseases, Metabolic;

2006
Inflammatory bowel disease in Thai children: presentations and outcomes of treatment.
    Asian Pacific journal of allergy and immunology, 2006, Volume: 24, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; C

2006
An audit of gastroduodenal Crohn disease: clinicopathologic features and management.
    Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Constriction, Pathologic; C

1999
chemdatabank.com